Membrane-bound Fas ligand only is essential for Fas-induced apoptosis (original) (raw)

• Hughes, P. D. et al. Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity. Immunity 28, 197–205 (2008)
  Article CAS Google Scholar
• Hutcheson, J. et al. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28, 206–217 (2008)
  Article CAS Google Scholar
• Weant, A. E. et al. Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction. Immunity 28, 218–230 (2008)
  Article CAS Google Scholar
• Krammer, P. H. CD95's deadly mission in the immune system. Nature 407, 789–795 (2000)
  Article ADS CAS Google Scholar
• Peter, M. E. et al. The CD95 receptor: apoptosis revisited. Cell 129, 447–450 (2007)
  Article CAS Google Scholar
• Watanabe-Fukunaga, R. et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274–1279 (1992)
  CAS PubMed Google Scholar
• Takahashi, T. et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969–976 (1994)
  Article CAS Google Scholar
• Rieux-Laucat, F. et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347–1349 (1995)
  Article ADS CAS Google Scholar
• Fisher, G. H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935–946 (1995)
  Article CAS Google Scholar
• Trambas, C. M. & Griffiths, G. M. Delivering the kiss of death. Nature Immunol. 4, 399–403 (2003)
  Article CAS Google Scholar
• Schulte, M. et al. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ. 14, 1040–1049 (2007)
  Article CAS Google Scholar
• Schneider, P. et al. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187, 1205–1213 (1998)
  Article CAS Google Scholar
• Tanaka, M., Itai, T., Adachi, M. & Nagata, S. Downregulation of Fas ligand by shedding. Nature Med. 4, 31–36 (1998)
  Article CAS Google Scholar
• Hohlbaum, A. M., Moe, S. & Marshak-Rothstein, A. Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival. J. Exp. Med. 191, 1209–1219 (2000)
  Article CAS Google Scholar
• Siegel, R. M. et al. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288, 2354–2357 (2000)
  Article ADS CAS Google Scholar
• Chen, J.-J., Sun, Y. & Nabel, G. J. Regulation of the proinflammatory effects of Fas ligand (CD95L). Science 282, 1714–1717 (1998)
  Article ADS CAS Google Scholar
• Wilson, N. S., Dixit, V. & Ashkenazi, A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nature Immunol. 10, 348–355 (2009)
  Article CAS Google Scholar
• Ahn, J. H. et al. Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. Mitogen-activated protein kinases and NF-κB-dependent gene expression. J. Biol. Chem. 276, 47100–47106 (2001)
  Article CAS Google Scholar
• Xiao, S., Jodo, S., Sung, S. S., Marshak-Rothstein, A. & Ju, S. T. A novel signaling mechanism for soluble CD95 ligand. Synergy with anti-CD95 monoclonal antibodies for apoptosis and NF-κB nuclear translocation. J. Biol. Chem. 277, 50907–50913 (2002)
  Article CAS Google Scholar
• Oliveira, J. B. et al. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc. Natl Acad. Sci. USA 104, 8953–8958 (2007)
  Article ADS CAS Google Scholar
• Kono, D. H. & Theofilopoulos, A. N. Genetic susceptibility to spontaneous lupus in mice. Curr. Dir. Autoimmun. 1, 72–98 (1999)
  Article CAS Google Scholar
• Watanabe, D., Suda, T., Hashimoto, H. & Nagata, S. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14, 12–18 (1995)
  Article CAS Google Scholar
• Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806–809 (1993)
  Article ADS CAS Google Scholar
• Huang, D. C. et al. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xL . Proc. Natl Acad. Sci. USA 96, 14871–14876 (1999)
  Article ADS CAS Google Scholar
• Strand, S. et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells—a mechanism of immune evasion? Nature Med. 2, 1361–1366 (1996)
  Article CAS Google Scholar
• Fredrickson, T. N. & Harris, A. W. Atlas of Mouse Hematopathology (Harwood Academic, 2000)
  Google Scholar
• Frith, C. H. & Wiley, L. D. Morphologic classification and correlation of incidence of hyperplastic and neoplastic hematopoietic lesions in mice with age. J. Gerontol. 36, 534–545 (1981)
  Article CAS Google Scholar
• Suzuki, I. & Fink, P. J. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187, 123–128 (1998)
  Article CAS Google Scholar
• Sun, M. & Fink, P. J. A new class of reverse signaling costimulators belongs to the TNF family. J. Immunol. 179, 4307–4312 (2007)
  Article CAS Google Scholar
• Karray, S. et al. Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele. J. Immunol. 172, 2118–2125 (2004)
  Article CAS Google Scholar
• Schwenk, F., Baron, U. & Rajewsky, K. A _cre_-transgenic mouse strain for the ubiquitous deletion of _loxP_-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080–5081 (1995)
  Article CAS Google Scholar
• Phillips, J. M., O'Reilly, L., Bland, C., Foulis, A. K. & Cooke, A. Patients with chronic pancreatitis have islet progenitor cells in their ducts, but reversal of overt diabetes in NOD mice by anti-CD3 shows no evidence for islet regeneration. Diabetes 56, 634–640 (2007)
  Article CAS Google Scholar
• Pileri, S. A. et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 41, 1–29 (2002)
  Article ADS CAS Google Scholar
• Blott, E. J., Bossi, G., Clark, R., Zvelebil, M. & Griffiths, G. M. Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail. J. Cell Sci. 114, 2405–2416 (2001)
  CAS PubMed Google Scholar
• Naik, S., Vremec, D., Wu, L., O'Keeffe, M. & Shortman, K. CD8α+ mouse spleen dendritic cells do not originate from the CD8 α-dendritic cell subset. Blood 102, 601–604 (2003)
  Article CAS Google Scholar
• Hibbs, M. L. et al. Multiple defects in the immune system of _Lyn_-deficient mice, culminating in autoimmune disease. Cell 83, 301–311 (1995)
  Article CAS Google Scholar
• Lyons, A. B. & Parish, C. R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171, 131–137 (1994)
  Article CAS Google Scholar
• Kilbourne, E. D. Future influenza vaccines and the use of genetic recombinants. Bull. WHO 41, 643–645 (1969)
  CAS PubMed Google Scholar
• Flynn, K. J. et al. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8, 683–691 (1998)
  Article CAS Google Scholar
• Belz, G. T., Xie, W., Altman, J. D. & Doherty, P. C. A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge. J. Virol. 74, 3486–3493 (2000)
  Article CAS Google Scholar
• Belz, G. T., Xie, W. & Doherty, P. C. Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses. J. Immunol. 166, 4627–4633 (2001)
  Article CAS Google Scholar